5-methoxypsoralen has been researched along with Shock in 1 studies
5-Methoxypsoralen: A linear furanocoumarin that has phototoxic and anti-inflammatory properties, with effects similar to METHOXSALEN. It is used in PUVA THERAPY for the treatment of PSORIASIS.
5-methoxypsoralen : A 5-methoxyfurocoumarin that is psoralen substituted by a methoxy group at position 5.
Shock: A pathological condition manifested by failure to perfuse or oxygenate vital organs.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, Y | 1 |
| Wang, J | 1 |
| Yang, W | 1 |
| Qi, X | 1 |
| Lan, L | 1 |
| Luo, L | 1 |
| Yin, Z | 1 |
1 other study available for 5-methoxypsoralen and Shock
| Article | Year |
|---|---|
Bergapten prevents lipopolysaccharide-induced inflammation in RAW264.7 cells through suppressing JAK/STAT activation and ROS production and increases the survival rate of mice after LPS challenge.
Topics: 5-Methoxypsoralen; Animals; Anti-Inflammatory Agents; Cell Survival; Cyclooxygenase 2; Cytokines; Ja | 2017 |